Talk:Epinephrine autoinjector
Jump to navigation
Jump to search
User:MiszaBot/config Template:Reliable sources for medical articles
<templatestyles src="Module:Message box/tmbox.css"/><templatestyles src="Talk header/styles.css" />
| This is the talk page for discussing improvements to the Epinephrine autoinjector Template:Pagetype. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Template:Find sources |
| Archives: Template:Comma separated entries<templatestyles src="Template:Tooltip/styles.css" />Auto-archiving periodScript error: No such module "Check for unknown parameters".: Template:Human readable duration File:Information icon4.svg |
Script error: No such module "Check for unknown parameters".Script error: No such module "Check for deprecated parameters".
Template:WikiProject banner shell
Missing information
- Mylan had an agreement with Pfizer, struck in 2010, for Pfizer to disinvest from Adrenaclick, which competed with Mylan's product, EpiPen. Pfizer was purchasing King Pharmaceuticals, which manufactured the drug that went into EpiPen, so giving up the profits from its selling of Adrenaclick would be more than made up for by higher profits from EpiPen sales. - https://theintercept.com/2021/09/07/joe-manchin-epipen-price-heather-bresch/
- Adrenaclick was discontinued - https://snacksafely.com/2018/08/epipen-generic-impax-auto-injector-sorting-through-the-lingo/ .